Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalNo recent work listed

Hao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9501-1885; OpenAlex author ID A5100446067. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer. First author DOI 10.3389/fendo.2023.1093042↗
  2. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism. Co-author DOI 10.1159/000494477↗
  3. MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. Co-author DOI 10.1186/s12935-016-0331-4↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan-Shu Lian · 1 shared paper, 2023 · strength 0.18
  2. Wenbo Zou · 1 shared paper, 2023 · strength 0.18
  3. Gao Huang · 1 shared paper, 2023 · strength 0.18
  4. Dehai Wu · 1 shared paper, 2018 · strength 0.08
  5. Shan Yu · 1 shared paper, 2018 · strength 0.08
  6. Lei Zhang · 1 shared paper, 2018 · strength 0.08
  7. Sheng Tai · 1 shared paper, 2018 · strength 0.08
  8. Cheng Hang · 1 shared paper, 2016 · strength 0.06
  9. Jianxin Zhu · 1 shared paper, 2016 · strength 0.06
  10. Xilong Ou · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.